Navigation Links
Inhaled Insulin: A New Modality for Management of Diabetes

It is widely known that diabetes, one of the world’s leading debilitating diseases, has reached overwhelming proportions // . It affects an estimated 194 million adults worldwide. Therefore, there is a huge demand for innovative and effective therapeutic options that are beneficial to the patients.

There are two types of diabetes:

Type-1: Also known as Juvenile Diabetes, it accounts for approximately 5% of all the cases. This type is the direct result of the body’s inability to produce sufficient Insulin required for the breakdown of sugar.

Type-2: This results from the body not availing the Insulin that is present and is often associated with ageing, obesity and lack of physical activity.

On Saturday (June 9, 2006) the pharmaceutical company, Pfizer, announced the arrival of its 'Inhaled Insulin' Exubera, which will be available from July all over the United States. It is the first non-injectable Insulin to be marketed and is a revolutionary change in the management of Diabetes. The drug has been approved by the FDA. This announcement was made by Pfizer, along with its partner Nektar Therapeutics, at the annual scientific meeting of the American Diabetics Association.

It is claimed that the drug is far more user- friendly than the injectable version. A price has not yet been assigned to the drug.

Having been approved by the EU, diabetics in Europe also will have access to the drug.

In the US, the drug has been approved to treat both Type 1 and Type 2 Diabetes. Taken at mealtime, the patient inhales the Insulin through the mouth and the drug then is rapidly delivered into the lungs. The lungs are considered a safe place for its absorption due to its large and permeable surface area. From here it pass into the blood stream.

Pfizer recommends that Type 1 patients use Exubera along with the injections, while the Type 2 patients may use it alone or in combination with the in jections or pills.

Exubera is a boon to those patients with Type 2 Diabetes who are reluctant to be initiated on injectable Insulin and thus delay the treatment by up to four years. They strongly believe that the drug will have a huge impact on the treatment and management of the disease.

A cautionary note from the critics say that small injections of Insulin are far more predictable than any prescribed dose of inhaled Insulin and that it cannot be said with any finality that the inhaled Insulin is definitely superior to its injectable counterpart.

Patients need to consult with their physicians about the utilization of this new mode of treatment for management of diabetes.


Related medicine news :

1. Inhaled Steroids Safe & Effective for Children with Asthma
2. Inhaled Corticosteroids Found To Have No Significant Effect On COPD
3. The Effectiveness Of Inhaled Corticosteroids Studied
4. The Effectiveness Of Inhaled Corticosteroids Studied
5. Inhaled nitric oxide therapy does not reduce death risk of infants
6. New Drug Exubera (Oral Inhaled Insulin) To Be Monitored By Pfizer
7. HIIP- A Novel Inhaled Insulin Delivery System As An Alternative To Injectable Insulin Therapy
8. Inhaled Insulin To Be Made Available in India
9. Inhaled Insulin Could Rock The Drug Market Soon
10. High Cost Forces NHS To Reject Inhaled Insulin
11. Inhaled Cyclosporine Results In Rejection Free Survival among Lung Transplant Patients
Post Your Comments:

(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from reveals that behind the tendency to set ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their ... Award, an essay contest in which patients and their families pay tribute to a ... the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... National recruitment firm ... life sciences executive with extensive sequencing and genomics experience, as Vice President of North ... Ms. Hill will be responsible for leading the sales team in the commercialization of ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology: